Related Experiment Video
Updated: Jun 6, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Depression in heart failure: biobehavioral mechanisms
Willem J Kop1, Stephen J Synowski, Stephen S Gottlieb
1Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA. w.j.kop@uvt.nl
Insights
Depression affects 1 in 5 heart failure patients, increasing mortality risk. Understanding its biobehavioral links is key for better treatments.
Area of Science:
- Cardiology
- Psychiatry
- Behavioral Medicine
Background:
- Depression is prevalent in heart failure (HF), affecting 20% of patients.
- Depression significantly worsens quality of life and doubles the risk of HF progression and mortality.
- Biobehavioral mechanisms, including inflammation and unhealthy behaviors, link depression to adverse HF outcomes.
Purpose of the Study:
- To describe the etiology, predictive value, and biobehavioral aspects of depression in heart failure.
- To highlight the impact of depression on HF progression and mortality.
- To inform the development of novel interventions.
Main Methods:
- Review of existing literature on depression in heart failure.
- Analysis of biobehavioral pathways connecting depression to HF outcomes.
- Evaluation of current treatment efficacy.
Main Results:
- Depression is linked to elevated neurohormones, autonomic dysregulation, inflammation, and poor health behaviors.
- Depression often goes undiagnosed due to symptom overlap with HF and lack of screening.
- Antidepressive interventions show modest improvements in depression and quality of life, but not consistently in HF outcomes.
Conclusions:
- Elucidating biobehavioral pathways is crucial for understanding depression's impact on HF.
- Novel integrative interventions targeting these pathways are needed.
- Systematic screening and targeted treatments are essential for managing depression in HF patients.
Abstract:
The etiology, predictive value, and biobehavioral aspects of depression in heart failure (HF) are described in this article. Clinically elevated levels of depressive symptoms are present in approximately 1 out of 5 patients with HF. Depression is associated with poor quality of life and a greater than 2-fold risk of clinical HF progression and mortality. The biobehavioral mechanisms accounting for these adverse outcomes include biological processes (elevated neurohormones, autonomic nervous system dysregulation, and inflammation) and adverse health behaviors (physical inactivity, medication nonadherence, poor dietary control, and smoking). Depression often remains undetected because of its partial overlap with HF-related symptoms and lack of systematic screening. Behavioral and pharmacologic antidepressive interventions commonly result in statistically significant but clinically modest improvements in depression and quality of life in HF, but not consistently better clinical HF or cardiovascular disease outcomes. Documentation of the biobehavioral pathways by which depression affects HF progression will be important to identify potential targets for novel integrative behavioral and pharmacologic interventions.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
